Joan Maurel

Joan Maurel

UNVERIFIED PROFILE

Are you Joan Maurel?   Register this Author

Register author
Joan Maurel

Joan Maurel

Publications by authors named "Joan Maurel"

Are you Joan Maurel?   Register this Author

84Publications

2634Reads

43Profile Views

The Tumor Microenvironment in Colorectal Cancer Therapy.

Cancers (Basel) 2019 Aug 14;11(8). Epub 2019 Aug 14.

Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721633PMC
August 2019

The controversy of neoadjuvant therapy in rectal cancer.

Cir Esp 2019 Aug - Sep;97(7):361-363. Epub 2019 Feb 14.

Gastrointestinal and Pancreatic Oncology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ciresp.2019.01.004DOI Listing
February 2019

Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected peritoneal carcinomatosis.

Pancreatology 2017 Sep - Oct;17(5):858-864. Epub 2017 Aug 19.

Endoscopy Unit, Gastroenterology Department, ICMDiM, IDIBAPS, CIBEREHD, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalunya, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2017.08.004DOI Listing
June 2018

Surgical management of adolescent and young adults with gastrointestinal stromal tumors: it is of value?

Transl Gastroenterol Hepatol 2017 7;2:86. Epub 2017 Nov 7.

Medical Oncology Service, Hospital Clínic Barcelona, Barcelona 08036, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tgh.2017.10.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723740PMC
November 2017

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.

Future Oncol 2017 10 13;13(23):2065-2082. Epub 2017 Jul 13.

Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0220DOI Listing
October 2017

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients.

ESMO Open 2017 3;2(3):e000187. Epub 2017 Aug 3.

European Society for Medical Oncology (ESMO), Clinic of Oncology,University Hospital, Zürich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634488PMC
August 2017

[Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma].

Med Clin (Barc) 2016 Nov 7;147(10):465.e1-465.e8. Epub 2016 Oct 7.

Servicio de Oncología Médica, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, España; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.07.033DOI Listing
November 2016

Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.

Curr Cancer Drug Targets 2015 ;15(8):703-15

Department of Medical Oncology, Hospital Clínic Barcelona, Villarroel 170, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/19/10/1046.fu
Web Search
July 2016

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

J Clin Oncol 2016 07 16;34(19):2294-302. Epub 2016 May 16.

Javier Martin-Broto, Virgen del Rocio Hospital and Biomedicine Institute, Sevilla; Antonio López Pousa, Sant Pau Hospital; Xavier García del Muro, Institut Català d'Oncologia; and Joan Maurel, CIBERehd, IDIBAPS, Hospital Clinic, Barcelona; Ramón de las Peñas, Provincial Hospital, Castellón; Antonio Gutierrez, Rafael Ramos, and Jordi Martinez-Serra, Son Espases Hospital; and Regina Alemany, Balearic Islands University, Palma de Mallorca; Javier Martinez-Trufero, Miguel Servet Hospital, Zaragoza; Josefina Cruz, University Hospital Canarias, Tenerife; Rosa Alvarez, Gregorio Marañón Hospital; Ricardo Cubedo, Puerta de Hierro Hospital; Andrés Redondo, La Paz University Hospital; José A. López-Martin, 12 de Octubre Hospital; and Ángeles Vaz, Ramón y Cajal Hospital, Madrid; Juan A. Carrasco, Xeral Cies Hospital, Vigo; Ángeles Sala and Ana De Juan, Basurto Hospital, Bilbao; José Andrés Meana, University General Hospital, Alicante; José A. Lopez-Guerrero and Andrés Poveda, Valencian Oncologic Institute, Valencia; Isabel Sevilla, Virgen de la Victoria Hospital, Málaga; and Carmen Balaña, Insitut Català d'Oncologia, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3329DOI Listing
July 2016

LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.

Mol Carcinog 2016 May 3;55(5):411-9. Epub 2015 Feb 3.

Departament de Ciències Fisiològiques I. Laboratori de Genètica Molecular, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22289DOI Listing
May 2016

Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials.

Int J Cancer 2015 May 3;136(10):2444-7. Epub 2014 Nov 3.

Department of Epidemiology, Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355231PMC
May 2015

An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer.

Oncologist 2014 Apr 27;19(4):350-1. Epub 2014 Mar 27.

Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (center affiliated with the Red Temática de Investigación Cooperativa en Cancer, Instituto Carlos III, Spanish Ministry of Science and Innovation), Sevilla, Spain;

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/19/4/350.full
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983832PMC
April 2014

Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.

Cancer 2014 Feb 14;120(3):454-6. Epub 2013 Nov 14.

Medical Oncology Service, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28449DOI Listing
February 2014

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.

Int J Cancer 2013 Mar 12;132(5):1090-7. Epub 2012 Aug 12.

Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, IDIBAPS*, University of Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27747DOI Listing
March 2013

Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer.

Med Oncol 2013 Mar 22;30(1):428. Epub 2013 Jan 22.

Medical Oncology Department, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-012-0428-0DOI Listing
March 2013

Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening.

Cell Oncol (Dordr) 2011 Dec 17;34(6):511-21. Epub 2011 Jun 17.

Departament de Bioquímica i Biologia Molecular, Institut de Biomedicina, Universitat de Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-011-0049-1DOI Listing
December 2011

[Malignancy predictive factors in pancreatic intraductal papillary mucinous neoplasm].

Med Clin (Barc) 2011 Nov 16;137(14):631-6. Epub 2011 Mar 16.

Servicio de Gastroenterología, Institut de Malalties Digestives i Metabòliques, IDIBAPS, CIBERehd, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2010.11.026DOI Listing
November 2011

EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.

Gastrointest Endosc 2011 Aug;74(2):347-54

Department of Gastroenterology, Institut de Malalties Digestives i Metabòliques, IDIBAPS, CIBERehd, Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2011.03.1257DOI Listing
August 2011

SEOM clinical guidelines for the treatment of anal cancer.

Clin Transl Oncol 2011 Aug;13(8):525-7

Medical Oncology Department, Hospital Clinic i Provincial de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0692-zDOI Listing
August 2011

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

Clin Transl Oncol 2011 Aug;13(8):536-44

Medical Oncology Department, Hospital Universitario La Paz (IdiPAZ), RETICC, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0694-xDOI Listing
August 2011

Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition.

Nutr Hosp 2010 Sep-Oct;25(5):736-40

Servei d'Endocrinologia i Nutrició, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
June 2011

Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD).

Rev Recent Clin Trials 2011 May;6(2):158-70

Medical Oncology, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
May 2011

Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.

Tumour Biol 2011 Apr 23;32(2):417-24. Epub 2010 Nov 23.

Medical Oncology Department, Institut Clínic Malalties Hemato-Oncológiques (ICMHO), Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERehd, Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s13277-010-0136
Web Search
http://link.springer.com/10.1007/s13277-010-0136-3
Publisher Site
http://dx.doi.org/10.1007/s13277-010-0136-3DOI Listing
April 2011

[Soft tissue sarcomas: clinical practice guidelines].

Med Clin (Barc) 2011 Apr 15;136(9):408.e1-8. Epub 2011 Mar 15.

Servicio de Oncología Médica, Instituto Catalán de Oncología L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2011.02.004DOI Listing
April 2011

[Incidence and characteristics of pancreatic cystic neoplasms].

Gastroenterol Hepatol 2010 Oct 20;33(8):563-8. Epub 2010 Sep 20.

Servicio de Gastroenterología, IDIBAPS, CIBERehd, Institut Malalties Digestives i Metabòliques, Hospital Clinic de Barcelona, Universidad de Barcelona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gastrohep.2010.07.001DOI Listing
October 2010

[Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part I). Grupo Español de Consenso en Cáncer de Páncreas].

Med Clin (Barc) 2010 May 26;134(14):643-55. Epub 2010 Mar 26.

Servicio de Gastroenterología, CIBERehd, IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2009.12.014DOI Listing
May 2010

[Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part II)].

Med Clin (Barc) 2010 May 30;134(15):692-702. Epub 2010 Mar 30.

Servicio de Gastroenterología, CIBERehd, IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2010.01.006DOI Listing
May 2010

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.

Invest New Drugs 2009 Jun 16;27(3):262-8. Epub 2008 Oct 16.

Medical Oncology Department, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, CIBERehd, University of Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-008-9192-6DOI Listing
June 2009

Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.

Ann Surg Oncol 2009 May 4;16(5):1412-20. Epub 2009 Mar 4.

Department of Medical Oncology, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Médica de Enfermedades Hepáticas y Digestivas, University of Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0405-9DOI Listing
May 2009

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.

PLoS One 2009 6;4(3):e4728. Epub 2009 Mar 6.

Facultat de Medicina, Hospital Clínic, Institut d'Investigacions Biomèdiques Agustí Pi y Sunyer, Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004728PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648894PMC
May 2009

Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer.

J Pain Symptom Manage 2009 Feb 23;37(2):135-43. Epub 2008 Aug 23.

Developmental Therapeutics and GI Malignancies, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2008.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856704PMC
February 2009

[Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].

Med Clin (Barc) 2009 Feb 7;132(5):163-71. Epub 2009 Feb 7.

Servicio de Gastroenterología, Institut de Malalties Digestives i Metabòliques, Hospital Clínic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERehd. Universidad de Barcelona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2008.07.012DOI Listing
February 2009

Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.

Cancer Chemother Pharmacol 2008 Nov 12;62(6):1075-83. Epub 2008 Mar 12.

Medical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Crta Canyet s/n, 08916, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-008-0700-3DOI Listing
November 2008

Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.

J Magn Reson Imaging 2008 Mar;27(3):625-8

Department of Radiation Oncology, Musculoskeletal Oncology Unit, Institute of Hematology and Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.21298DOI Listing
March 2008

Is there a genetic signature for liver metastasis in colorectal cancer?

World J Gastroenterol 2007 Nov;13(44):5832-44

Servei Oncologia Mèdica, Institut Clínic de Malalties Hemato-Oncològiques, Hospital Clinic de Barcelona, c/Villarroel, 170, Barcelona 08036, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205430PMC
http://dx.doi.org/10.3748/wjg.v13.i44.5832DOI Listing
November 2007

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.

Int J Cancer 2007 Sep;121(5):1066-71

Medical Oncology Service, Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, CIBERehd. Universitat de Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22799DOI Listing
September 2007

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.

Int J Radiat Oncol Biol Phys 2006 Dec 11;66(5):1391-8. Epub 2006 Sep 11.

Medical Oncology Department, Hospital Clinic, Institut dé Investigacions Biomediques Científiques Agustí Pi I Suryer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.07.008DOI Listing
December 2006

Chemotherapy for elderly patients with advanced colorectal carcinoma.

Expert Rev Anticancer Ther 2006 May;6(5):795-800

Medical Oncology Service, Villarroel 170, 08036, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.5.795DOI Listing
May 2006

Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivity.

Rev Recent Clin Trials 2006 May;1(2):113-8

Medical Oncology Department ICMHO, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
May 2006

FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.

Clin Cancer Res 2005 Jul;11(13):4770-4

Medical Oncology, Institut Malalties Hemato-Oncologiques, Gastroenterology Department, Hospital Clinic Barcelona, Institut d'Investigacions Bimédiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2119DOI Listing
July 2005

Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.

Int J Radiat Oncol Biol Phys 2005 May;62(1):91-6

Department of Medical Oncology, Hospital Clinic Barcelona, Institut D'Investigacìons Bìomèdìques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.09.009DOI Listing
May 2005

Late-occurring liver metastases in colorectal cancer.

Dig Dis Sci 2005 Feb;50(2):345-7

Gastroenterology Department, Institut de Malalties Digestives, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-005-1608-yDOI Listing
February 2005

Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer.

Anticancer Drugs 2003 Feb;14(2):111-8

Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001813-200302000-00004DOI Listing
February 2003